Specifically, molecules inhibiting the Wnt pathway, such as sclerostin and dickkopf-1 (Dkk1), have been found to be abnormally expressed in RA patients compared to both healthy individuals and those with other inflammatory rheumatic musculoskeletal diseases7–9. The gene discussed is DKK1; the disease is rheumatoid arthritis.